3Chih H J, Lee AH, Colville L,et al. A review of dietary prevention of human papillomavirus-related infection of the cervix and cervical in- traepithelial neoplasia[ J]. Nutr Cancer,2013,65 (3) :317-328.
4Haghshenas M, Golini-Moghaddam T, Rafiei A, et al. Prev- alence and type distribution of high-risk human papilloma- virus in patients with cervical cancer: a population-based study[ J]. Infect Agent Cancer,2013,8 ( 1 ) :20.
5Song SH,Lee JK,Oh MJ,et al ter conization in patients with Persistent HPV infection af- negative margins [ J ]. Gyne-col 0ncol,2006,101 (3) :418.
6Nagai N, Mukai K, Oshita T, et al. Human papillomavirus DNA status after loop excision for cervical intraepithelial neoplasia grade Ⅲ :a prospective study [ J ]. Int J Mol Med, 2004,13 (4) :589.
7Lorinez AT, Richart RM. Human papillomavirus DNA tes- ting as an adjunct to cytology in cervical screening pro- grams [ J ]. Arch Pathol Lab Med,2003,127 ( 8 ) :959.
8Kim YT, Lee JM, Hur SY,et al. Clearance of human papil- lomavirus infection after successful conization in patients with cervical intraepithelial neoplasia [ J ]. Int J Cancer, 2010,126(8) :1903.
9Ryu A, Nam K, Kwak J, et al. Early human papillomavirus testing predicts residual/recurrent disease after LEEP [ J ]. J Gynecol Oncol,2012,23(4) :217.
10Strander B, Andersson-Ellstrom A, Milsom I, et al. Long term risk of invasive cancer after treatment for cervical intraepithelial neoplasia grade 3: population based cohort study [J]. BMJ, 2007,335 (7629) : 1077.
